Skip to main content
. Author manuscript; available in PMC: 2023 May 14.
Published in final edited form as: J Immunother. 2017 Jan;40(1):31–35. doi: 10.1097/CJI.0000000000000148

FIGURE 2.

FIGURE 2.

(A) PFS and (B) OS from the start of anti-programmed cell death-1 (PD-1) in the anti-PD-1 first group (labeled “anti-PD-1,” black) versus the BRAFi-first group (labeled “BRAFi,” red). (C) PFS and (D) OS from the start of BRAFi in the anti-PD-1 first group versus the BRAFi-first group.